C4 Therapeutics Stock Price on July 22, 2025
| CCCC Stock | USD 2.10 0.02 0.94% |
If you're considering investing in CCCC Stock, it is important to understand the factors that can impact its price. As of today, the current price of C4 Therapeutics stands at 2.10, as last reported on the 5th of August, with the highest price reaching 2.15 and the lowest price hitting 2.04 during the day. C4 Therapeutics appears to be dangerous, given 3 months investment horizon. C4 Therapeutics retains Efficiency (Sharpe Ratio) of 0.12, which signifies that the company had a 0.12 % return per unit of price deviation over the last 3 months. By evaluating C4 Therapeutics' technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please makes use of C4 Therapeutics' Standard Deviation of 6.39, market risk adjusted performance of (1.42), and Coefficient Of Variation of 864.59 to double-check if our risk estimates are consistent with your expectations. CCCC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
C4 Therapeutics Valuation on July 22, 2025
It is possible to determine the worth of C4 Therapeutics on a given historical date. On July 22, 2025 CCCC was worth 2.28 at the beginning of the trading date compared to the closed value of 2.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of C4 Therapeutics stock. Still, in general, we apply an absolute valuation method to find C4 Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of C4 Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against C4 Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.37 | 2.48 | 2.26 | 2.27 | 1,305,532 | |
07/22/2025 | 2.28 | 2.30 | 2.15 | 2.22 | 866,998 |
| 2.24 | 2.53 | 2.19 | 2.42 | 1,368,192 |
| Backtest C4 Therapeutics | | | C4 Therapeutics History | | | C4 Therapeutics Valuation | Previous | Next |
C4 Therapeutics Trading Date Momentum on July 22, 2025
| On July 23 2025 C4 Therapeutics was traded for 2.42 at the closing time. The top price for the day was 2.53 and the lowest listed price was 2.19 . The trading volume for the day was 1.4 M. The trading history from July 23, 2025 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 9.01% . The overall trading delta against the current closing price is 9.01% . |
C4 Therapeutics Fundamentals Correlations and Trends
By evaluating C4 Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among C4 Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CCCC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About C4 Therapeutics Stock history
C4 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CCCC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in C4 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing C4 Therapeutics stock prices may prove useful in developing a viable investing in C4 Therapeutics
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. C4 Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 121 people.
C4 Therapeutics Stock Technical Analysis
C4 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
C4 Therapeutics Period Price Range
Low | August 5, 2025
| High |
0.00 | 0.00 |
C4 Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
C4 Therapeutics August 5, 2025 Market Strength
Market strength indicators help investors to evaluate how C4 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading C4 Therapeutics shares will generate the highest return on investment. By undertsting and applying C4 Therapeutics stock market strength indicators, traders can identify C4 Therapeutics entry and exit signals to maximize returns
C4 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for C4 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CCCC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CCCC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1014 | |||
| Jensen Alpha | 0.7889 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.1205 | |||
| Treynor Ratio | (1.43) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for CCCC Stock analysis
When running C4 Therapeutics' price analysis, check to measure C4 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C4 Therapeutics is operating at the current time. Most of C4 Therapeutics' value examination focuses on studying past and present price action to predict the probability of C4 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C4 Therapeutics' price. Additionally, you may evaluate how the addition of C4 Therapeutics to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |